Mucopolysaccharidosis Type 4 (MPS IV, Morquio Syndrome)
Symptoms, Doctors, Treatments, Advances & More

Mucopolysaccharidosis Type 4 (MPS IV, Morquio Syndrome) Overview

Save information for later
Sign Up

Learn About Mucopolysaccharidosis Type 4 (MPS IV, Morquio Syndrome)

View Main Condition: Mucopolysaccharidoses (MPS)

What is the definition of Mucopolysaccharidosis Type 4 (MPS IV, Morquio Syndrome)?
Mucopolysaccharidosis type IV (MPS IV), also known as Morquio syndrome, is a rare metabolic condition in which the body is unable to break down long chains of sugar molecules called glycosaminoglycans. As a result, toxic levels of these sugars accumulate in cell structures called lysosomes, leading to the various signs and symptoms associated with the condition. These signs and symptoms may include abnormalities of the skeleton, eyes, heart and respiratory system. There are two forms of MPS IV. MPS IVA is caused by changes in the GALNS gene. MPS IVB is caused by genetic changes in the GLB1 gene. Both forms are inherited in an autosomal recessive manner.
What are the alternative names for Mucopolysaccharidosis Type 4 (MPS IV, Morquio Syndrome)?
  • Mucopolysaccharidosis type IV
  • MPS4
  • MPSIV
  • Morquio disease
  • Mucopolysaccharidosis type 4
What are the different types of Mucopolysaccharidosis Type 4 (MPS IV, Morquio Syndrome)?
Who are the top Mucopolysaccharidosis Type 4 (MPS IV, Morquio Syndrome) Local Doctors?
Elite in Mucopolysaccharidosis Type 4 (MPS IV, Morquio Syndrome)
Pediatric Gastroenterology
Elite in Mucopolysaccharidosis Type 4 (MPS IV, Morquio Syndrome)
Pediatric Gastroenterology
Referral may be required

UCSF Benioff Children's Hospital Oakland

747 52nd St, 
Oakland, CA 
Languages Spoken:
English
Offers Telehealth

Paul Harmatz is a Pediatric Gastroenterologist practicing medicine in Oakland, California. Dr. Harmatz is rated as an Elite provider by MediFind in the treatment of Mucopolysaccharidosis Type 4 (MPS IV, Morquio Syndrome). He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Mucopolysaccharidoses (MPS), Mucopolysaccharidosis Type 6 (MPS VI, Maroteaux-Lamy Syndrome), Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome), and Mucopolysaccharidosis Type 4 (MPS IV, Morquio Syndrome). Dr. Harmatz is board certified in American Board Of Pediatrics.

Elite in Mucopolysaccharidosis Type 4 (MPS IV, Morquio Syndrome)
Elite in Mucopolysaccharidosis Type 4 (MPS IV, Morquio Syndrome)
Referral may be required

Nemours Children's Hospital Delaware

1600 Rockland Rd, 
Wilmington, DE 
Languages Spoken:
English

William Mackenzie is an Orthopedics provider practicing medicine in Wilmington, Delaware. Dr. Mackenzie is rated as an Elite provider by MediFind in the treatment of Mucopolysaccharidosis Type 4 (MPS IV, Morquio Syndrome). He is also highly rated in 59 other conditions, according to our data. His clinical expertise encompasses Mucopolysaccharidosis Type 4 (MPS IV, Morquio Syndrome), Brachydactyly Mononen Type, Achondroplasia, Osteotomy, and Spinal Fusion.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Mucopolysaccharidosis Type 4 (MPS IV, Morquio Syndrome)
Elite in Mucopolysaccharidosis Type 4 (MPS IV, Morquio Syndrome)
Referral may be required
Florence, IT 

Amelia Morrone practices practicing medicine in Florence, Italy. Ms. Morrone is rated as an Elite expert by MediFind in the treatment of Mucopolysaccharidosis Type 4 (MPS IV, Morquio Syndrome). She is also highly rated in 17 other conditions, according to our data. Her clinical expertise encompasses Mucopolysaccharidosis Type 4 (MPS IV, Morquio Syndrome), Brachydactyly Mononen Type, Mucopolysaccharidosis Type 4A (MPS IVA, Morquio Syndrome Type A), and PMM2-Congenital Disorder of Glycosylation.

What are the latest Mucopolysaccharidosis Type 4 (MPS IV, Morquio Syndrome) Clinical Trials?
Non-invasive Functional Assessment and Pathogenesis of Morquio A (NIFAMA)

Summary: Morquio A disease is a devastating systemic skeletal disease in which detailed progression and pathogenesis remain unknown. The proposed project aims to establish a non-invasive objective assessment that can be applicable to all ages of patients to better understand the progress of their disease and the most serious clinical problems (cervical instability and stenosis, tracheal obstruction, hyperl...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Effects of Bisphosphonates on OI-Related Hearing Loss: A Pilot Study

Summary: Osteogenesis Imperfecta-related hearing loss usually occurs in individuals with mild (type I) OI and is much earlier in onset than age-related hearing loss, with the majority of individuals experiencing some minor hearing loss in their 20s. Bisphosphonates have been successfully used to treat otosclerosis, a common cause of hearing loss similar to OI-related hearing loss. As many individuals with ...

Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center